COVID-19 Virtual Partnering Virtual event
20.04.20 - 06.05.20
As COVID-19 continues to advance around the world, it falls to pharmaceutical companies, biotechs, academia, research scientists, public health agencies, VCs, CRO/CMOs and their suppliers to coordinate the industry’s response to the COVID-19 pandemic.
In normal times, thousands of organizations would gather in a large conference center to meet and exchange. Clearly and unfortunately, that is not an option today.
Instead, leveraging its biopharma industry expertise, its leading digital networking platform and years of experience organizing partnering events, Inova is organizing a free Virtual Partnering Event to foster connections and accelerate global collaboration.
From 20 April to 6 May 2020, a consortium of Biotech clusters, Inova and Evaluate Ltd, are hosting a free COVID-19 Virtual Partnering event to bring together the key leaders and decision makers in the global pharma industry to connect and help bring forward solutions. This includes the development, trials and manufacture of patient solutions such as diagnostics, drug treatment and, ultimately, a COVID-19 vaccine.
The one-on-one virtual meetings will take place over the course of three days, on 4-5-6 May.
For more information please visit the event website.
This virtual event is endorsed by EFPIA.
In normal times, thousands of organizations would gather in a large conference center to meet and exchange. Clearly and unfortunately, that is not an option today.
Instead, leveraging its biopharma industry expertise, its leading digital networking platform and years of experience organizing partnering events, Inova is organizing a free Virtual Partnering Event to foster connections and accelerate global collaboration.
From 20 April to 6 May 2020, a consortium of Biotech clusters, Inova and Evaluate Ltd, are hosting a free COVID-19 Virtual Partnering event to bring together the key leaders and decision makers in the global pharma industry to connect and help bring forward solutions. This includes the development, trials and manufacture of patient solutions such as diagnostics, drug treatment and, ultimately, a COVID-19 vaccine.
The one-on-one virtual meetings will take place over the course of three days, on 4-5-6 May.
For more information please visit the event website.
This virtual event is endorsed by EFPIA.